KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News
Por un escritor de hombre misterioso
KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.
A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young
2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Cardiovascular Digital Health Journal
A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young
New FDA guidance allows use of KardiaMobile 6L to measure QTc in COVID-19 patients
2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart
NICE publishes first draft guidance from its Early Value Assessment pilot project recommending smartphone-linked ECG device, News, News
Alivecor Newsroom
Mayo Clinic research yields breakthrough in mobile determination of QT prolongation - Mayo Clinic News Network
Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients
Implementation of a fully remote randomized clinical trial with cardiac monitoring
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
Using 12-Lead ECG to Detect Drug-Induced Long QT Interval: The Gold Standard
What's the difference between KardiaMobile and KardiaMobile 6L?
KardiaStation